<DOC>
	<DOCNO>NCT00450723</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , thoracoscopic sentinel lymph node biopsy , may help find breast cancer spread lymph nodes breast . It may also help doctor plan best treatment . PURPOSE : This clinical trial study well thoracoscopic sentinel lymph node biopsy find sentinel lymph node locate breast patient stage I stage II breast cancer .</brief_summary>
	<brief_title>Thoracoscopic Sentinel Lymph Node Biopsy Patients With Stage I Stage II Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine occurrence rate internal mammary sentinel lymph nodes patient medially centrally locate stage I II breast cancer . - Determine safety , feasibility , success rate thorascopic internal mammary sentinel lymph node biopsy patient . - Determine rate metastatic disease internal mammary sentinel lymph node obtain thoracoscopically patient . OUTLINE : Patients undergo standard axillary sentinel lymph node dissection surgery ( i.e. , lumpectomy mastectomy ) . Patients receive radioactive tracer ( i.e. , technetium Tc 99m sulfur colloid ) isosulfan blue peritumoral injection identification axillary internal mammary sentinel lymph node ( IMSLN ) . Identified axillary sentinel lymph node dissect . Identified IMSLNs remove lumpectomy/mastectomy incision , accessible . If accessible , patient undergo thorascopic IMSLN biopsy remove node . All remove sentinel lymph node ( axillary internal mammary ) examine gross microscopic carcinoma future therapy planning . PROJECTED ACCRUAL : A total 50 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Technetium Tc 99m Sulfur Colloid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm breast cancer Stage I II disease ( T1T2 , N0 , M0/MX disease ) No chest wall invasion tumor ( T3 disease ) Medially centrally locate lesion No multicentric disease Multifocal disease allow No clinically positive axillary node No enlarge internal mammary node CT scan Hormone receptor status specify PATIENT CHARACTERISTICS : Male female Menopausal status specify American Society Anesthesiologists ( ASA ) physical status classification 12 Not pregnant nursing Negative pregnancy test No concurrent know , invasive malignancy No known chronic pulmonary disease No known allergy methylene blue isosulfan blue PRIOR CONCURRENT THERAPY : No prior thoracic cardiac surgery No prior ipsilateral chest tube placement Contralateral chest tube placement allow No prior neoadjuvant chemotherapy No prior radiotherapy mediastinum</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>male breast cancer</keyword>
</DOC>